Cater Barnard PLC
11 July 2003
FOR IMMEDIATE RELEASE 11th July 2003
CATER BARNARD PLC
Cater Barnard plc ('the Company') announces that it has today sold a total of
9,608,713 ordinary shares in Cater Barnard (USA) plc at a price of 2p per share,
raising £192,174 before expenses to add to cash reserves. This is a continuation
of the directors' strategy of realising the Company's investments. The Company
now retains 8,355,280 shares in Cater Barnard (USA) plc, approximately 32.16% of
the issued shares.
Minlay Limited has acquired 7,756,113 of the shares sold by the Company.
First Financial Securities Limited has acquired 1,852,600 shares. Adrian Stecyk,
a director of the Company is beneficially interested in all the shares held by
First Financial.
The Company also announces that it has exercised and sold its remaining options
in Medicis Pharmaceutical Corp. raising a further $US156,000 (£ 95,790) to
add to cash deposits
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.